Cargando…
The role of implantable cardioverter-defibrillators in New York Heart Class I heart failure patients: do not abandon the asymptomatic just yet
Autores principales: | van der Lingen, Anne-Lotte C J, Allaart, Cornelis P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263698/ https://www.ncbi.nlm.nih.gov/pubmed/32211875 http://dx.doi.org/10.1093/eurheartj/ehaa180 |
Ejemplares similares
-
Incident heart failure risk after bariatric surgery: the role of epicardial fat
por: van Woerden, Gijs, et al.
Publicado: (2020) -
Combined extracardiac ultrasound in heart failure: a step forward in congestion assessment
por: Anastasiou, Vasileios, et al.
Publicado: (2023) -
What to do with the equipoise?
por: Knol, Wiebe G, et al.
Publicado: (2019) -
How do Regulatory T Cells Work?
por: Corthay, A
Publicado: (2009) -
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
por: Pappone, Carlo, et al.
Publicado: (2021)